Keywords: fda, rejects, nastech, new, drug, application, motion

FDA rejects Nastech's New Drug Application for motion sickness drug

Article | 24 February 2000

Print This

Nasal delivery specialist Nastech has been informed by the US Food andDrug Administration that the agency has rejected its New ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in